feed,title,long_url,short_url
Benzinga,"The global biologics CDMO market (henceforth, referred to as the market studied) was valued at USD 9.93 billion in 2020, and it is expected to reach USD 18.90 billion by 2026, registering a CAGR of 11.2% during 2021-2026",https://benzinga.com/pressreleases/21/03/g20011876/the-global-biologics-cdmo-market-henceforth-referred-to-as-the-market-studied-was-valued-at-usd-9-,
